title: Deferasirox improves hematopoiesis after allogeneic hematopoietic SCT.
authors.affiliation: Hematology and Hematopoietic Stem Cell Centre, AORMN Marche Nord, Pesaro, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Visani
authors.affiliation: Hematology and Hematopoietic Stem Cell Centre, AORMN Marche Nord, Pesaro, Italy.
authors.forename: B
authors.initials: B
authors.lastname: Guiducci
authors.affiliation: Hematology and Hematopoietic Stem Cell Centre, AORMN Marche Nord, Pesaro, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Giardini
authors.affiliation: Hematology and Hematopoietic Stem Cell Centre, AORMN Marche Nord, Pesaro, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Loscocco
authors.affiliation: Hematology and Hematopoietic Stem Cell Centre, AORMN Marche Nord, Pesaro, Italy.
authors.forename: T
authors.initials: T
authors.lastname: Ricciardi
authors.affiliation: Hematology and Hematopoietic Stem Cell Centre, AORMN Marche Nord, Pesaro, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Isidori
mesh_terms: D001565:Benzoates / Q000627:therapeutic use*; D000077588:Deferasirox; D006410:Hematopoiesis / Q000187:drug effects*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D019190:Iron Overload / Q000188:drug therapy*; D014184:Transplantation, Homologous; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D001565:Benzoates; D007502:Iron Chelating Agents; D014230:Triazoles; D000077588:Deferasirox